The geometric mean peak plasma concentration (C(max)) of rosuvastatin was 6.06 ng/mL and was reached at a median of 5 hours after dosing. At C(max)
The geometric mean peak plasma concentration (C(max)) of rosuvastatin was 6.06 ng/mL and was reached at a median of 5 hours after dosing. At C(max)
by PD Martin 2024 Cited by 337The geometric mean peak plasma concentration (C(max)) of rosuvastatin was 6.06 ng/mL and was reached at a median of 5 hours after dosing. At C(max)
Ciclosporin: Avoid use. If use cannot be avoided, Max rosuvastatin dose is 5 mg once daily. Gemfibrozil: Avoid use. If use cannot be avoided, initiate rosuvastatin at 5 mg once daily. Max: 10 mg once daily. Atazanavir/ritonavir, lopinavir/ritonavir, or simeprevir: Initiate rosuvastatin at 5 mg once daily. Max: 10 mg once daily. Pharmacogenomics:
If use cannot be avoided, Max rosuvastatin dose is 5 mg once daily. Gemfibrozil: Avoid use. If use cannot be avoided, initiate rosuvastatin at 5 mg once daily.
Ciclosporin: Avoid use. If use cannot be avoided, Max rosuvastatin dose is 5 mg once daily. Gemfibrozil: Avoid use. If use cannot be avoided, initiate rosuvastatin at 5 mg once daily. Max: 10 mg once daily. Atazanavir/ritonavir, lopinavir/ritonavir, or simeprevir: Initiate rosuvastatin at 5 mg once daily. Max: 10 mg once daily. Pharmacogenomics:
40 mg dose is contraindicated. Patients receiving concomitant therapy: Ciclosporin: Avoid use. If use cannot be avoided, Max rosuvastatin dose is 5 mg once
Ciclosporin: Avoid use. If use cannot be avoided, Max rosuvastatin dose is 5 mg once daily. Gemfibrozil: Avoid use. If use cannot be avoided, initiate rosuvastatin at 5 mg once daily. Max: 10 mg once daily. Atazanavir/ritonavir, lopinavir/ritonavir, or simeprevir: Initiate rosuvastatin at 5 mg once daily. Max: 10 mg once daily. Pharmacogenomics:
40 mg dose is contraindicated. Patients receiving concomitant therapy: Ciclosporin: Avoid use. If use cannot be avoided, Max rosuvastatin dose is 5 mg once
Comments